ResearchHub | Open Science Community

Nicholas McCarthy

Author with expertise in Acute Myeloid Leukemia

Achievements

This user has not unlocked any achievements yet.

Key Stats

Upvotes received:

Publications:

(0% Open Access)

Cited by:

h-index:

i10-index:

Reputation

Biology

< 1%

Chemistry

< 1%

Economics

< 1%

How is this calculated?

Publications

Evaluating UNet Performance in Segmenting Cysts of Diffuse Cystic Lung Disease CT Scans

Katie Noonan et al.Sep 14, 2024

Internal Medicine

Pulmonary And Respiratory Medicine

Paper

Internal Medicine

Pulmonary And Respiratory Medicine

Save

Impact of Cytogenetics, Induction Chemotherapy and MRD on Outcomes of Intensively Treated AML with KMT2A Rearrangements - Experience from UK NCRI AML17 and AML19

Jad Othman et al.Nov 5, 2024

Paper

Save

A Randomised Comparison of CPX-351 Versus Standard Daunorubicin and Cytarabine Plus Fractionated Gemtuzumab Ozogamicin in Older Adults with AML without Adverse Risk Cytogenetics: Results of the NCRI AML18 Trial

Steven Knapper et al.Nov 5, 2024

Paper

Save

Treatment Intensification With Either Fludarabine, AraC, G-CSF and Idarubicin, or Cladribine Plus Daunorubicin and AraC on the Basis of Residual Disease Status in Older Patients With AML: Results From the NCRI AML18 Trial.

Nigel Russell et al.Nov 18, 2024

To evaluate the survival benefit of chemotherapy intensification in older patients with AML who have not achieved a measurable residual disease (MRD)-negative remission.

Paper

Save